TY  - GEN
AU  - Al-Laith,Mariam
AU  - Jasenecova,Marianna
AU  - Abraham,Sonya
AU  - Bosworth,Aisla
AU  - Bruce,Ian N
AU  - Buckley,Christopher D
AU  - Ciurtin,Coziana
AU  - D'Agostino,Maria-Antonietta
AU  - Emery,Paul
AU  - Gaston,Hill
AU  - Isaacs,John D
AU  - Filer,Andrew
AU  - Fisher,Benjamin A
AU  - Huizinga,Thomas W J
AU  - Ho,Pauline
AU  - Jacklin,Clare
AU  - Lempp,Heidi
AU  - McInnes,Iain B
AU  - Pratt,Arthur G
AU  - Östor,Andrew
AU  - Raza,Karim
AU  - Taylor,Peter C
AU  - van Schaardenburg,Dirkjan
AU  - Shivapatham,Dharshene
AU  - Wright,Alison J
AU  - Vasconcelos,Joana C
AU  - Kelly,Joanna
AU  - Murphy,Caroline
AU  - Prevost,A Toby
AU  - Cope,Andrew P
TI  - Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol
SN  - 1745-6215
PY  - 2020///0205
KW  - Abatacept
KW  - administration & dosage
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - diagnosis
KW  - Autoantibodies
KW  - blood
KW  - Biomarkers
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Male
KW  - Multicenter Studies as Topic
KW  - Netherlands
KW  - Pregnancy
KW  - Randomized Controlled Trials as Topic
KW  - Time Factors
KW  - Treatment Outcome
KW  - United Kingdom
N1  - Publication Type: Clinical Trial Protocol; Journal Article
UR  - https://doi.org/10.1186/s13063-019-3403-7
ER  -